Nishma M. Ramzanali

Development and validation of an ultra-deep next-generation sequencing assay for 1 testing of plasma cell-free DNA from patients with advanced cancer 2

G. Mills, S. Gnerre, Richard Shen, 2017 .

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF‐mutated melanoma and other advanced malignancies

F. Meric-Bernstam, S. Patel, R. Kurzrock, 2018, Cancer.

BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System

G. Mills, F. Meric-Bernstam, S. Patel, 2016, Molecular Cancer Therapeutics.

Development and Validation of an Ultradeep Next-Generation Sequencing Assay for Testing of Plasma Cell-Free DNA from Patients with Advanced Cancer

G. Mills, Han-Yu Chuang, Jian-Bing Fan, 2017, Clinical Cancer Research.

Abstract 2413: Rapid, automated BRAF mutation testing of cell-free DNA from plasma of patients with advanced cancers using the novel Idylla platform

F. Meric-Bernstam, S. Patel, R. Kurzrock, 2015 .